Related Experiment Videos
The role of proto-oncogenes in coronary restenosis
1Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA.
Abstract:
Arterial injury results in exposure of medial smooth muscle cells and adventitial fibroblasts to multiple growth factors that bind to specific cell surface receptors. These in turn activate second messengers and induce expression of immediate-early genes within minutes to hours after ligand binding to the receptor. Activation of the immediate-early genes results in passage of the stimulated cell from its nonproliferating, quiescent G0 state to the first phase of the cell cycle (G1). Coordination of the events that occur during the cell cycle is effected by a series of cyclin-dependent kinases and requires inactivation of several "tumor suppressor genes," including p53, p21, p16, p15, p27, and the retinoblastoma gene Rb, that inhibit the kinase activity of the cyclin/Cdk complexes. An understanding of the factors that regulate signal transduction, cell cycle progression, and programmed cell death has suggested several novel therapeutic strategies including (1) antisense oligonucleotide inhibition of proto-oncogene expression, (2) the use of molecular decoys or pharmacological therapies to block specific steps required for cell cycle progression, and (3) gene transfer of tumor suppressor genes. The apparent success of several of these strategies in animal models of restenosis suggests that these molecular therapies may play a valuable role in preventing intimal hyperplasia and restenosis after balloon angioplasty and vascular stenting.
Insights
Arterial injury triggers cell cycle progression via growth factors and immediate-early genes. Novel molecular therapies targeting cell cycle regulation show promise in preventing restenosis after angioplasty.
Area of Science:
- Vascular Biology
- Cell Cycle Regulation
- Molecular Therapeutics
Background:
- Arterial injury exposes cells to growth factors, initiating signaling cascades.
- These signals activate immediate-early genes, driving quiescent cells into the G1 phase of the cell cycle.
- Cell cycle progression is tightly regulated by cyclin-dependent kinases and tumor suppressor genes.
Purpose of the Study:
- To explore therapeutic strategies for preventing vascular restenosis.
- To investigate the role of signal transduction, cell cycle progression, and programmed cell death in arterial injury response.
Main Methods:
- Review of signaling pathways involved in cell cycle regulation post-arterial injury.
- Analysis of therapeutic approaches including antisense oligonucleotides, molecular decoys, and gene transfer.
- Evaluation of strategies in animal models of restenosis.
Main Results:
- Understanding of molecular mechanisms regulating signal transduction and cell cycle progression.
- Identification of novel therapeutic strategies targeting these pathways.
- Demonstration of potential efficacy of these strategies in animal models.
Conclusions:
- Novel molecular therapies targeting cell cycle regulation offer a promising approach.
- These strategies may prevent intimal hyperplasia and restenosis following procedures like balloon angioplasty and vascular stenting.